Content about AndroGel

April 1, 2013
Actavis seeks approval for additional strength of generic testosterone gel

Just a week after the Supreme Court heard the Federal Trade Commission's lawsuit over its deal with AbbVie to sell a generic version of a testosterone-replacement therapy, Actavis is challenging the patent on another strength of the drug.

March 15, 2013
FDA approves new packet version of AbbVie testosterone gel

The Food and Drug Administration has approved a new pocket-sized packet option for a testosterone-replacement therapy made by AbbVie, the drug maker said Friday.

March 5, 2013
GPhA defends patent settlements as Supreme Court date nears

The stakes are high in a case involving generic drug maker Actavis and the Federal Trade Commission that will soon go before the Supreme Court, the head of a generic drug industry lobbying group said in a conference call with reporters Tuesday.

January 8, 2013
Abbott spins off new drug company

Abbott Labs has spun off its specialty drug division into a new company called AbbVie, which the new company's leaders heralded Wednesday by ringing the first opening bell of 2013 at the New York Stock Exchange.

November 2, 2011
Perrigo seeks approval for generic version of Abbott's Androgel

Drug maker Perrigo has filed for regulatory approval of a generic topical drug for treating testosterone deficiency, prompting a patent infringement suit from the branded version's manufacturer.

May 2, 2011
FDA approves Abbott's AndroGel

The Food and Drug Administration has approved a treatment made by Abbott for low testosterone in men, the drug maker said Friday.

© 2013 Drug Store News. All Rights Reserved.